Gain-of-Function Mutations in TRPM4 Cause Autosomal Dominant Isolated Cardiac Conduction Disease

Background—Isolated cardiac conduction block is a relatively common condition in young and elderly populations. Genetic predisposing factors have long been suspected because of numerous familial case reports. Deciphering genetic predisposing factors of conduction blocks may give a hint at stratifying conduction block carriers in a more efficient way. Methods and Results—One Lebanese family and 2 French families with autosomal dominant isolated cardiac conduction blocks were used for linkage analysis. A maximum combined multipoint lod score of 10.5 was obtained on a genomic interval including more than 300 genes. After screening 12 genes of this interval for mutation, we found a heterozygous missense mutation of the TRPM4 gene in each family (p.Arg164Trp, p.Ala432Thr, and p.Gly844Asp). This gene encodes the TRPM4 channel, a calcium-activated nonselective cation channel of the transient receptor potential melastatin (TRPM) ion channel family. All 3 mutations result in an increased current density. This gain of function is due to an elevated TRPM4 channel density at the cell surface secondary to impaired endocytosis and deregulation of Small Ubiquitin MOdifier conjugation (SUMOylation). Furthermore, we showed by immunohistochemistry that TRPM4 channel signal level is higher in atrial cardiomyocytes than in common ventricular cells, but is highest in Purkinje fibers. Small bundles of highly TRPM4-positive cells were found in the subendocardium and in rare intramural bundles. Conclusions—the TRPM4 gene is a causative gene in isolated cardiac conduction disease with mutations resulting in a gain of function and TRPM4 channel being highly expressed in cardiac Purkinje fibers.

[1]  Y. Aizawa,et al.  Novel Mechanisms of Trafficking Defect Caused by KCNQ1 Mutations Found in Long QT Syndrome* , 2009, The Journal of Biological Chemistry.

[2]  E. Schulze-Bahr,et al.  Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. , 2009, Journal of Clinical Investigation.

[3]  B. Nilius,et al.  Modulation of TRPs by PIPs , 2007, The Journal of physiology.

[4]  M. Eldar,et al.  Point Mutation in the HCN4 Cardiac Ion Channel Pore Affecting Synthesis, Trafficking, and Functional Expression Is Associated With Familial Asymptomatic Sinus Bradycardia , 2007, Circulation.

[5]  K. Cornils,et al.  Modulation of Ca2+ entry and plasma membrane potential by human TRPM4b , 2007, The FEBS journal.

[6]  P. Launay,et al.  TRPM4, a Ca2+-activated nonselective cation channel in mouse sino-atrial node cells. , 2007, Cardiovascular research.

[7]  Ho Yin Chan,et al.  Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO-specific protease. , 2006, The Biochemical journal.

[8]  C. January,et al.  Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism , 2006, Circulation.

[9]  Tom H. Lindner,et al.  easyLINKAGE-Plus--automated linkage analyses using large-scale SNP data , 2005, Bioinform..

[10]  J. Kinet,et al.  TRPM4 Regulates Calcium Oscillations After T Cell Activation , 2004, Science.

[11]  H. Morita,et al.  Functional Characterization of a Trafficking-defective HCN4 Mutation, D553N, Associated with Cardiac Arrhythmia* , 2004, Journal of Biological Chemistry.

[12]  B. Nilius,et al.  Intracellular nucleotides and polyamines inhibit the Ca2+-activated cation channel TRPM4b , 2004, Pflügers Archiv.

[13]  M. Freichel,et al.  Voltage Dependence of the Ca2+-activated Cation Channel TRPM4* , 2003, Journal of Biological Chemistry.

[14]  P. O’Hare,et al.  Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. , 2002, The Journal of general virology.

[15]  T. N. James,et al.  Structure and function of the sinus node, AV node and His bundle of the human heart: part I-structure. , 2002, Progress in cardiovascular diseases.

[16]  A. Perraud,et al.  TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization , 2002, Cell.

[17]  S. Müller,et al.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Schroer,et al.  Role of dynactin in endocytic traffic: effects of dynamitin overexpression and colocalization with CLIP-170. , 1999, Molecular biology of the cell.

[19]  A. Wilde,et al.  Cardiac conduction defects associate with mutations in SCN5A , 1999, Nature Genetics.

[20]  J. Seidman,et al.  Congenital heart disease caused by mutations in the transcription factor NKX2-5. , 1998, Science.

[21]  C. Echeverri,et al.  Cytoplasmic Dynein and Dynactin Are Required for the Transport of Microtubules into the Axon , 1998, The Journal of cell biology.

[22]  C. Echeverri,et al.  Overexpression of the Dynamitin (p50) Subunit of the Dynactin Complex Disrupts Dynein-dependent Maintenance of Membrane Organelle Distribution , 1997, The Journal of cell biology.

[23]  P. Bouvagnet,et al.  Hereditary bundle branch defect: right bundle branch blocks of different causes have different morphologic characteristics. , 1997, American heart journal.

[24]  J. Weissenbach,et al.  An isolated cardiac conduction disease maps to chromosome 19q. , 1995, Circulation research.

[25]  W H Lamers,et al.  Immunohistochemical delineation of the conduction system. II: The atrioventricular node and Purkinje fibers. , 1993, Circulation research.

[26]  L. Thornell,et al.  Monoclonal antibody to desmin purified from cow Purkinje fibers reveals a cell‐type specific determinant , 1990, FEBS letters.

[27]  H. Ulrich,et al.  The SUMO system: an overview. , 2009, Methods in molecular biology.

[28]  D. Hodge,et al.  Association of uncomplicated electrocardiographic conduction blocks with subsequent cardiac morbidity in a community-based population (Olmsted County, Minnesota). , 2008, The American journal of cardiology.

[29]  S. Chiu,et al.  Cardiac conduction disturbance detected in a pediatric population. , 2008, The Journal of pediatrics.

[30]  R. Vennekens,et al.  Insights into TRPM4 function, regulation and physiological role. , 2007, Handbook of experimental pharmacology.

[31]  Eric S. Lander,et al.  Faster Multipoint Linkage Analysis Using Fourier Transforms , 1998, J. Comput. Biol..